container_end_page 148
container_issue 2
container_start_page 73
container_title Medicinal research reviews
container_volume 12
creator Longman, Susan D.
Hamilton, Thomas C.
description
doi_str_mv 10.1002/med.2610120202
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73036357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73036357</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4892-4d96eb91c4cbc707cd84087fd9b0ea79359e9ad374fc90662aca0fb2df02ccbc3</originalsourceid><addsrcrecordid>eNqFkM1v1DAQxS0EKkvhyg3JJ07N4o8kjrmh7RdSFxAfReJiTZxJ15DEwXZa-t-TJVURJzSHGen33tPoEfKcszVnTLzqsVmLkjMu2DwPyIozXWWci-ohWTE-36UUxWPyJMbvjHFecHlADnghi1LlK9J_8AlidFNP7Q6GATsKNrlrSD7QJkxX8TXd4h652FPf_qF-OKLjDkIP1nf-ylno6Bj8iCE5jEcUhoamHQYYcUrO0tEnHJKD7il51EIX8dndPiRfTk8-b86zi_dnbzdvLjKbV1pkeaNLrDW3ua2tYso2Vc4q1Ta6ZghKy0KjhkaqvLWalaUAC6ytRdMyYWeLPCQvl9z5q58TxmR6Fy12HQzop2iUZLKUhZqF60Vog48xYGvG4HoIt4Yzs-_XzP2av_3Ohhd3yVO9R_fypdCZ64XfuA5v_5NmtifH_2Rni9fFhL_uvRB-mFJJVZiv787Mx8vt5vTbp0tzLn8DEzmY3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73036357</pqid></control><display><type>article</type><title>Potassium channel activator drugs: Mechanism of action, pharmacological properties, and therapeutic potential</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Longman, Susan D. ; Hamilton, Thomas C.</creator><creatorcontrib>Longman, Susan D. ; Hamilton, Thomas C.</creatorcontrib><identifier>ISSN: 0198-6325</identifier><identifier>EISSN: 1098-1128</identifier><identifier>DOI: 10.1002/med.2610120202</identifier><identifier>PMID: 1535674</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; Antihypertensive Agents - classification ; Antihypertensive Agents - pharmacology ; Antihypertensive Agents - therapeutic use ; Benzopyrans - classification ; Benzopyrans - pharmacology ; Benzopyrans - therapeutic use ; Cardiovascular System - drug effects ; Central Nervous System - drug effects ; Clinical Trials as Topic ; Cromakalim ; Disease Models, Animal ; Guanidines - classification ; Guanidines - pharmacology ; Guanidines - therapeutic use ; Humans ; Muscle, Smooth, Vascular - drug effects ; Muscles - drug effects ; Neurons - drug effects ; Niacinamide - analogs &amp; derivatives ; Niacinamide - classification ; Niacinamide - pharmacology ; Niacinamide - therapeutic use ; Nicorandil ; Pancreas - drug effects ; Pinacidil ; Potassium Channels - drug effects ; Pyrroles - classification ; Pyrroles - pharmacology ; Pyrroles - therapeutic use ; Vasodilator Agents - classification ; Vasodilator Agents - pharmacology ; Vasodilator Agents - therapeutic use</subject><ispartof>Medicinal research reviews, 1992-03, Vol.12 (2), p.73-148</ispartof><rights>Copyright © 1992 Wiley Periodicals, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4892-4d96eb91c4cbc707cd84087fd9b0ea79359e9ad374fc90662aca0fb2df02ccbc3</citedby><cites>FETCH-LOGICAL-c4892-4d96eb91c4cbc707cd84087fd9b0ea79359e9ad374fc90662aca0fb2df02ccbc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmed.2610120202$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmed.2610120202$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1535674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Longman, Susan D.</creatorcontrib><creatorcontrib>Hamilton, Thomas C.</creatorcontrib><title>Potassium channel activator drugs: Mechanism of action, pharmacological properties, and therapeutic potential</title><title>Medicinal research reviews</title><addtitle>Med. Res. Rev</addtitle><subject>Animals</subject><subject>Antihypertensive Agents - classification</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Benzopyrans - classification</subject><subject>Benzopyrans - pharmacology</subject><subject>Benzopyrans - therapeutic use</subject><subject>Cardiovascular System - drug effects</subject><subject>Central Nervous System - drug effects</subject><subject>Clinical Trials as Topic</subject><subject>Cromakalim</subject><subject>Disease Models, Animal</subject><subject>Guanidines - classification</subject><subject>Guanidines - pharmacology</subject><subject>Guanidines - therapeutic use</subject><subject>Humans</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Muscles - drug effects</subject><subject>Neurons - drug effects</subject><subject>Niacinamide - analogs &amp; derivatives</subject><subject>Niacinamide - classification</subject><subject>Niacinamide - pharmacology</subject><subject>Niacinamide - therapeutic use</subject><subject>Nicorandil</subject><subject>Pancreas - drug effects</subject><subject>Pinacidil</subject><subject>Potassium Channels - drug effects</subject><subject>Pyrroles - classification</subject><subject>Pyrroles - pharmacology</subject><subject>Pyrroles - therapeutic use</subject><subject>Vasodilator Agents - classification</subject><subject>Vasodilator Agents - pharmacology</subject><subject>Vasodilator Agents - therapeutic use</subject><issn>0198-6325</issn><issn>1098-1128</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1v1DAQxS0EKkvhyg3JJ07N4o8kjrmh7RdSFxAfReJiTZxJ15DEwXZa-t-TJVURJzSHGen33tPoEfKcszVnTLzqsVmLkjMu2DwPyIozXWWci-ohWTE-36UUxWPyJMbvjHFecHlADnghi1LlK9J_8AlidFNP7Q6GATsKNrlrSD7QJkxX8TXd4h652FPf_qF-OKLjDkIP1nf-ylno6Bj8iCE5jEcUhoamHQYYcUrO0tEnHJKD7il51EIX8dndPiRfTk8-b86zi_dnbzdvLjKbV1pkeaNLrDW3ua2tYso2Vc4q1Ta6ZghKy0KjhkaqvLWalaUAC6ytRdMyYWeLPCQvl9z5q58TxmR6Fy12HQzop2iUZLKUhZqF60Vog48xYGvG4HoIt4Yzs-_XzP2av_3Ohhd3yVO9R_fypdCZ64XfuA5v_5NmtifH_2Rni9fFhL_uvRB-mFJJVZiv787Mx8vt5vTbp0tzLn8DEzmY3w</recordid><startdate>199203</startdate><enddate>199203</enddate><creator>Longman, Susan D.</creator><creator>Hamilton, Thomas C.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199203</creationdate><title>Potassium channel activator drugs: Mechanism of action, pharmacological properties, and therapeutic potential</title><author>Longman, Susan D. ; Hamilton, Thomas C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4892-4d96eb91c4cbc707cd84087fd9b0ea79359e9ad374fc90662aca0fb2df02ccbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Antihypertensive Agents - classification</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Benzopyrans - classification</topic><topic>Benzopyrans - pharmacology</topic><topic>Benzopyrans - therapeutic use</topic><topic>Cardiovascular System - drug effects</topic><topic>Central Nervous System - drug effects</topic><topic>Clinical Trials as Topic</topic><topic>Cromakalim</topic><topic>Disease Models, Animal</topic><topic>Guanidines - classification</topic><topic>Guanidines - pharmacology</topic><topic>Guanidines - therapeutic use</topic><topic>Humans</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Muscles - drug effects</topic><topic>Neurons - drug effects</topic><topic>Niacinamide - analogs &amp; derivatives</topic><topic>Niacinamide - classification</topic><topic>Niacinamide - pharmacology</topic><topic>Niacinamide - therapeutic use</topic><topic>Nicorandil</topic><topic>Pancreas - drug effects</topic><topic>Pinacidil</topic><topic>Potassium Channels - drug effects</topic><topic>Pyrroles - classification</topic><topic>Pyrroles - pharmacology</topic><topic>Pyrroles - therapeutic use</topic><topic>Vasodilator Agents - classification</topic><topic>Vasodilator Agents - pharmacology</topic><topic>Vasodilator Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Longman, Susan D.</creatorcontrib><creatorcontrib>Hamilton, Thomas C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medicinal research reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Longman, Susan D.</au><au>Hamilton, Thomas C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potassium channel activator drugs: Mechanism of action, pharmacological properties, and therapeutic potential</atitle><jtitle>Medicinal research reviews</jtitle><addtitle>Med. Res. Rev</addtitle><date>1992-03</date><risdate>1992</risdate><volume>12</volume><issue>2</issue><spage>73</spage><epage>148</epage><pages>73-148</pages><issn>0198-6325</issn><eissn>1098-1128</eissn><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>1535674</pmid><doi>10.1002/med.2610120202</doi><tpages>76</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0198-6325
ispartof Medicinal research reviews, 1992-03, Vol.12 (2), p.73-148
issn 0198-6325
1098-1128
language eng
recordid cdi_proquest_miscellaneous_73036357
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Antihypertensive Agents - classification
Antihypertensive Agents - pharmacology
Antihypertensive Agents - therapeutic use
Benzopyrans - classification
Benzopyrans - pharmacology
Benzopyrans - therapeutic use
Cardiovascular System - drug effects
Central Nervous System - drug effects
Clinical Trials as Topic
Cromakalim
Disease Models, Animal
Guanidines - classification
Guanidines - pharmacology
Guanidines - therapeutic use
Humans
Muscle, Smooth, Vascular - drug effects
Muscles - drug effects
Neurons - drug effects
Niacinamide - analogs & derivatives
Niacinamide - classification
Niacinamide - pharmacology
Niacinamide - therapeutic use
Nicorandil
Pancreas - drug effects
Pinacidil
Potassium Channels - drug effects
Pyrroles - classification
Pyrroles - pharmacology
Pyrroles - therapeutic use
Vasodilator Agents - classification
Vasodilator Agents - pharmacology
Vasodilator Agents - therapeutic use
title Potassium channel activator drugs: Mechanism of action, pharmacological properties, and therapeutic potential
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T15%3A35%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potassium%20channel%20activator%20drugs:%20Mechanism%20of%20action,%20pharmacological%20properties,%20and%20therapeutic%20potential&rft.jtitle=Medicinal%20research%20reviews&rft.au=Longman,%20Susan%20D.&rft.date=1992-03&rft.volume=12&rft.issue=2&rft.spage=73&rft.epage=148&rft.pages=73-148&rft.issn=0198-6325&rft.eissn=1098-1128&rft_id=info:doi/10.1002/med.2610120202&rft_dat=%3Cproquest_cross%3E73036357%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73036357&rft_id=info:pmid/1535674&rfr_iscdi=true